Annual CAPEX
N/A
December 31, 2024
Summary
- AMPH annual capital expenditures is not available.
Performance
AMPH CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
December 31, 2024
Summary
- AMPH quarterly capital expenditures is not available.
Performance
AMPH Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
December 31, 2024
Summary
- AMPH TTM capital expenditures is not available.
Performance
AMPH TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
AMPH CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AMPH CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Amphastar Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.79 M(+128.2%) | $38.07 M(+10.4%) |
| Jun 2024 | - | $6.04 M(-31.3%) | $34.47 M(-8.0%) |
| Mar 2024 | - | $8.79 M(-6.9%) | $37.48 M(-1.8%) |
| Dec 2023 | $38.17 M(+58.8%) | $9.44 M(-7.4%) | $38.17 M(+8.9%) |
| Sep 2023 | - | $10.19 M(+12.6%) | $35.03 M(+15.0%) |
| Jun 2023 | - | $9.05 M(-4.5%) | $30.46 M(+11.3%) |
| Mar 2023 | - | $9.48 M(+50.2%) | $27.37 M(+13.9%) |
| Dec 2022 | $24.03 M(-12.5%) | $6.31 M(+12.2%) | $24.03 M(-2.3%) |
| Sep 2022 | - | $5.62 M(-5.7%) | $24.60 M(-6.1%) |
| Jun 2022 | - | $5.96 M(-2.9%) | $26.20 M(+0.9%) |
| Mar 2022 | - | $6.14 M(-10.7%) | $25.98 M(-5.4%) |
| Dec 2021 | $27.46 M(-18.9%) | $6.88 M(-4.7%) | $27.46 M(-8.2%) |
| Sep 2021 | - | $7.22 M(+25.7%) | $29.91 M(+5.6%) |
| Jun 2021 | - | $5.74 M(-24.6%) | $28.32 M(-15.4%) |
| Mar 2021 | - | $7.62 M(-18.3%) | $33.47 M(-1.1%) |
| Dec 2020 | $33.85 M(-18.5%) | $9.33 M(+65.7%) | $33.85 M(+2.8%) |
| Sep 2020 | - | $5.63 M(-48.3%) | $32.94 M(-8.5%) |
| Jun 2020 | - | $10.89 M(+36.0%) | $35.98 M(+3.8%) |
| Mar 2020 | - | $8.01 M(-4.8%) | $34.67 M(-16.6%) |
| Dec 2019 | $41.55 M(-11.2%) | $8.41 M(-3.1%) | $41.55 M(-2.7%) |
| Sep 2019 | - | $8.68 M(-9.3%) | $42.73 M(-8.5%) |
| Jun 2019 | - | $9.57 M(-35.7%) | $46.68 M(-5.4%) |
| Mar 2019 | - | $14.89 M(+55.4%) | $49.36 M(+5.5%) |
| Dec 2018 | $46.81 M | $9.58 M(-24.2%) | $46.81 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $12.63 M(+3.1%) | $47.34 M(+2.6%) |
| Jun 2018 | - | $12.25 M(-0.7%) | $46.12 M(+14.8%) |
| Mar 2018 | - | $12.34 M(+22.0%) | $40.17 M(+14.5%) |
| Dec 2017 | $35.10 M(+64.2%) | $10.12 M(-11.3%) | $35.10 M(+15.8%) |
| Sep 2017 | - | $11.41 M(+81.1%) | $30.32 M(+18.4%) |
| Jun 2017 | - | $6.30 M(-13.3%) | $25.61 M(+3.7%) |
| Mar 2017 | - | $7.27 M(+36.2%) | $24.70 M(+15.5%) |
| Dec 2016 | $21.38 M(+33.7%) | $5.34 M(-20.4%) | $21.38 M(+6.3%) |
| Sep 2016 | - | $6.70 M(+24.1%) | $20.11 M(+13.5%) |
| Jun 2016 | - | $5.40 M(+36.8%) | $17.73 M(+12.4%) |
| Mar 2016 | - | $3.95 M(-3.0%) | $15.77 M(-1.4%) |
| Dec 2015 | $16.00 M(-22.0%) | $4.07 M(-5.6%) | $16.00 M(-22.9%) |
| Sep 2015 | - | $4.31 M(+25.3%) | $20.75 M(+0.5%) |
| Jun 2015 | - | $3.44 M(-17.6%) | $20.66 M(+1.0%) |
| Mar 2015 | - | $4.17 M(-52.7%) | $20.45 M(-0.2%) |
| Dec 2014 | $20.50 M(+12.0%) | $8.83 M(+109.2%) | $20.50 M(+32.0%) |
| Sep 2014 | - | $4.22 M(+30.7%) | $15.53 M(-2.0%) |
| Jun 2014 | - | $3.23 M(-23.6%) | $15.85 M(-1.3%) |
| Mar 2014 | - | $4.23 M(+9.6%) | $16.07 M(-12.2%) |
| Dec 2013 | $18.30 M(-27.5%) | $3.86 M(-15.1%) | $18.30 M(+26.7%) |
| Sep 2013 | - | $4.54 M(+31.9%) | $14.45 M(+45.9%) |
| Jun 2013 | - | $3.44 M(-46.7%) | $9.90 M(+53.3%) |
| Mar 2013 | - | $6.46 M | $6.46 M |
| Dec 2012 | $25.25 M(+135.5%) | - | - |
| Dec 2011 | $10.72 M | - | - |
FAQ
- What is the all time high annual CAPEX for Amphastar Pharmaceuticals?
- What is the all time high quarterly CAPEX for Amphastar Pharmaceuticals?
- What is the all time high TTM CAPEX for Amphastar Pharmaceuticals?
What is the all time high annual CAPEX for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual capital expenditures is $46.81 M
What is the all time high quarterly CAPEX for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly capital expenditures is $14.89 M
What is the all time high TTM CAPEX for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM capital expenditures is $49.36 M